<DOC>
	<DOCNO>NCT00987844</DOCNO>
	<brief_summary>Objectives : To evaluate clinical long-term safety tolerability , patient satisfaction , pharmacokinetics use pattern prucalopride give dos 4 mg per day patient chronic constipation ( CC ) .</brief_summary>
	<brief_title>Study Evaluate Long-Term Safety , Tolerability , Satisfaction With Prucalopride Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Male nonpregnant , non breastfeed female outpatient least 18 year age . 2 . Patient complete entire treatment period one follow study : PRUUSA3 , PRUUSA11 , PRUUSA13 , PRUUSA21 , PRUUSA25 , PRUUSA27 PRUUSA28 , Patient participate retreatment study PRUUSA28 qualify Treatment period II washout period . 1 . Patient impair renal function 2 . Patient clinically significant abnormality haematology , urinalysis , blood chemistry . 3 . Female childbearing potential without adequate contraceptive protection study . 4 . Patient use investigation drug prucalopride 30 day precede study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>